US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 66.675
  • -0.165-0.25%
Trading Jan 7 15:52 ET
206.77BMarket Cap32.13P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.535B--
--2024/Q4-- / 14.250B--
Nov 12, 20242024/Q313.565B / 13.102B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.535B--
--2024/Q4-- / 14.250B--
Nov 12, 20242024/Q313.565B / 13.102B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--

Unlock Free Earnings Estimates

AstraZeneca Earnings Reports

  • 6-K: 9M and Q3 2024 Results

    Nov 12, 2024 13:43 ET

  • 6-K: AstraZeneca Invests $3.5 Billion in US

    Nov 12, 2024 09:28 ET

  • 6-K: H1 and Q2 2024 Results

    Jul 25, 2024 09:09 ET

  • AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

    May 21, 2024 06:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+1.28%